Constellation Brands enters the back half of August with short sellers pressing harder into the stock — yet the borrow market remains so loose that the position growth looks opportunistic rather than urgent.
Short interest climbed nearly 6% on the week and 13% over the past month, reaching 4.9% of the free float with around 8.5 million shares short. That is a meaningful build, but the lending backdrop offers no drama. Availability is running at roughly 3,400% — meaning shares available to borrow outnumber shares already borrowed by a wide margin, the most relaxed reading the stock has seen in the past year. Cost to borrow dropped sharply too, falling to just 0.13% on August 18 from around 0.41% a week earlier, a 65% decline. Together, these signals paint a picture of shorts adding to positions into softness, with no squeeze pressure and ample room to grow. Options traders have nudged slightly more defensive — the put/call ratio moved to 0.87, a little above its 20-day average of 0.84 — but the z-score of 1.25 puts that nowhere near a stress reading. Positioning looks opportunistic rather than anxious.
The Street remains split, and recent analyst moves have mostly been target reductions without rating changes — a soft vote of caution rather than outright bearishness. After the fiscal Q1 print in early July, Barclays cut its target to $132, essentially in line with where the stock now trades. JPMorgan trimmed to $165, Deutsche Bank to $150, and Morgan Stanley moved down sharply from $183 to $158, all maintaining neutral or hold-equivalent ratings. The bulls have not blinked: BMO Capital holds at Outperform with a $190 target, Roth Capital at Buy with $209, and RBC at Outperform with $185. The mean target across the panel is around $171, implying roughly 30% upside from current levels — a gap that reflects how far the stock has drifted from where analysts thought it would be. The EV/EBITDA multiple has compressed to about 10.2x, and the P/E sits near 11.4x, both edging up modestly over the past month as the share price steadied. The dividend yield factor ranks in the 89th percentile, a reminder that income-oriented holders have a reason to stay.
The bull case centres on beer market share gains, class-leading brand health metrics, and a leaner portfolio following the disposal of underperforming wine brands. Bears point to slowing momentum in the US beer market, production risks tied to Mexican operations, and an increasingly cautious consumer in the Hispanic demographic that drives much of STZ's volume. The ORTEX short score of 41.4 is broadly stable — no strong directional signal — and EPS momentum ranks in the 43rd percentile on both the 30- and 90-day windows, indicating the earnings revision cycle has yet to turn constructively. Peers moved in a similar direction on the week: TAP fell roughly 2% and BF.B shed 3.1%, suggesting broader sector pressure rather than anything specific to STZ. DGE on the LSE dropped 4.4%, the weakest of the peer group.
The next scheduled earnings release falls on October 2. The past three prints each produced an initial negative reaction — moves of roughly -1% to -2% on the day — with mixed five-day follow-throughs. One print saw a modest five-day recovery; the others extended lower by 5-6%. The pattern suggests the market has not found a catalyst to reprice the stock higher off results alone. What to watch is whether the short interest build continues at its current pace into September, and whether analyst targets begin to converge further toward the current price or instead stabilise as a sign that the Street sees the downside as increasingly priced in.
See the live data behind this article on ORTEX.
Open STZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
